600211.SS
600211.SS
CNE000000ZW7
TIBET RHODIOLA PHARMACEUTICAL H
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
11.85B EUR
12.05B EUR
13.08B EUR
13.71B EUR
Enterprise Value
9.45B EUR
10.2B EUR
11.31B EUR
12.19B EUR
Valuation Multiples
Trailing P/E
12.02x
14.62x
16.09x
17.5x
Forward P/E
8.84x
--
--
--
Price to Sales
4.11x
4.93x
5.12x
5.39x
Price to Book
2.99x
3.08x
3.35x
3.61x
EV/Revenue
3.28x
4.17x
4.43x
4.79x
EV/EBITDA
10.69x
11.22x
12.45x
13.83x
Price to FCF (P/FCF)
29.07x
15.88x
13.73x
15.63x
EV/FCF
23.17x
13.45x
11.87x
13.89x
FCF Yield
3.44%
6.3%
7.28%
6.4%
ende